Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Financials | 8.97% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3476
Celularity
CELU
$20.1M
| $22.9K | ﹤0.01% |
11,000
-12,380
| -53% | -$29.5K |
|
3477
DSS Inc
DSS
$5.18M
| $22.7K | ﹤0.01% |
25,248
+2,000
| +9% | +$2.23K |
|
|
SYRS
3478
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $22.1K | ﹤0.01% |
96,042
-393
| -0.4% | -$472 |
|
|
STKH
3479
Steakholder Foods
STKH
$1.7M
| $22.1K | ﹤0.01% |
+108
| New | +$31.2K |
|
3480
VerifyMe
VRME
$9.06M
| $21.6K | ﹤0.01% |
15,900
+2,000
| +14% | +$2.02K |
|
3481
OLB
OLB
$4.58M
| $21.6K | ﹤0.01% |
+10,437
| New | +$21K |
|
3482
Motorsport Games
MSGM
$18.7M
| $20.4K | ﹤0.01% |
+15,253
| New | +$19.2K |
|
3483
Moleculin Biotech
MBRX
$4.06M
| $19.5K | ﹤0.01% |
460
+20
| +5% | +$1.21K |
|
3484
IT Tech Packaging
ITP
$2.88M
| $19.5K | ﹤0.01% |
32,418
+300
| +0.9% | +$77 |
|
3485
Globus Maritime Ltd
GLBS
$80.3M
| $19.1K | ﹤0.01% |
+16,300
| New | +$25K |
|
|
OKYO
3486
OKYO Pharma
OKYO
$79.2M
| $19K | ﹤0.01% |
+16,500
| New | +$17.7K |
|
3487
BeyondSpring
BYSI
$41M
| $18.9K | ﹤0.01% |
11,600
-100
| -0.9% | -$197 |
|
3488
AGM Group Holdings
AGMH
$2.24M
| $18.7K | ﹤0.01% |
248
+36
| +17% | +$3.13K |
|
|
GLXG
3489
Galaxy Payroll Group
GLXG
$6.8M
| $17.9K | ﹤0.01% |
+1,808
| New | +$113K |
|
|
XHG
3490
XChange TEC
XHG
$211M
| $17.6K | ﹤0.01% |
+1,020
| New | +$53.6K |
|
3491
Alzamend Neuro
ALZN
$7M
| $17.4K | ﹤0.01% |
+1,667
| New | +$21.4K |
|
|
BACK
3492
DELISTED
IMAC Holdings, Inc. Common Stock
BACK
| $17.3K | ﹤0.01% |
+13,600
| New | +$15.8K |
|
3493
Cenntro
CENN
$8.41M
| $17K | ﹤0.01% |
+265
| New | +$19.2K |
|
|
CISS
3494
C3is
CISS
$121K
| $16.8K | ﹤0.01% |
+14
| New | +$28.3K |
|
|
AIFA
3495
All In FutureTech Alliance Inc
AIFA
$18.6M
| $16.3K | ﹤0.01% |
3,433
+16
| +0.5% | +$102 |
|
|
BVC
3496
BitVentures Limited Ordinary Shares
BVC
$2.53B
| $16.1K | ﹤0.01% |
13,100
-13,800
| -51% | -$12.9K |
|
3497
Azitra
AZTR
$2.27M
| $15.6K | ﹤0.01% |
+5,491
| New | +$17.9K |
|
3498
Mustang Bio
MBIO
$4.5M
| $15.5K | ﹤0.01% |
+1,750
| New | +$19.3K |
|
3499
OneMedNet
ONMD
$44.3M
| $14.7K | ﹤0.01% |
10,845
-5,655
| -34% | -$5.06K |
|
3500
MoneyHero
MNY
$41M
| $14.6K | ﹤0.01% |
+13,000
| New | +$14.7K |
|
Similar funds
Jim Simons's Q4 2024 Portfolio in Review
As of Q4 2024, Jim Simons held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Jim Simons's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Jim Simons added most to Alibaba in Q4 2024, an estimated $191M increase.
- Jim Simons's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Jim Simons fully exited Arm in Q4 2024, selling an estimated $153M.
- Jim Simons's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Jim Simons opened 548 new positions and closed 497 in Q4 2024.
- Jim Simons's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.